Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells by Xiaofei Wei, Lin Shen, Chang Liu, Cheng Zhang, Min Tao, Jian Li, Xicheng Wang, Ting He, Fei Dai, Changsong Qi, Mingyang Ma, Yanping Ding, Xinan Lu, Dongqun Liu

Get full text

Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification by Jiajia Yuan, Lin Shen, Tian Shu Liu, HuiTing Xu, Jianwei Yang, Jia Wei, Haiping Jiang, Yanhong Deng, Hongming Pan, Yusheng Wang, Xiaotian Zhang, Zhi Peng, Changsong Qi, Lingli Zhang, Peiwen Hsu, Lin Song, Lei Mu, Qiao Sun, Jifang Gong, Cheng Lyu

Get full text

PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-cente... by Yakun Wang, Jialin Lu, Xiaoyi Chong, Chang Wang, Xiaofeng Chen, Zhi Peng, Yanhong Gu, Yizhuo Wang, Xicheng Wang, Jian Li, Jifang Gong, Changsong Qi, Jiajia Yuan, Zhihao Lu, Ming Lu, Jun Zhou, Yanshuo Cao, Yang Chen, Cheng Zhang, Zhiguo Hou, Hongyi Kou, Lin Shen, Xiaotian Zhang

Get full text

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a... by Dan Liu, Jifang Gong, Jian Li, Changsong Qi, Zuoxing Niu, Bo Liu, Zhi Peng, Suxia Luo, Xicheng Wang, Yakun Wang, Rusen Zhao, Lilin Chen, Ting Deng, Zhen Li, Lei Chen, Meimei Fang, Hongwei Yang, Linzhi Lu, Yanming Zhang, Fengling Kang, Ting Xu, Xiaotian Zhang, Lin Shen

Get full text